MA51521A - Compositions pharmaceutiques à libération immédiate contenant un sel de lysine de kétoprofène - Google Patents

Compositions pharmaceutiques à libération immédiate contenant un sel de lysine de kétoprofène

Info

Publication number
MA51521A
MA51521A MA051521A MA51521A MA51521A MA 51521 A MA51521 A MA 51521A MA 051521 A MA051521 A MA 051521A MA 51521 A MA51521 A MA 51521A MA 51521 A MA51521 A MA 51521A
Authority
MA
Morocco
Prior art keywords
pharmaceutical compositions
compositions containing
immediate release
release pharmaceutical
lysine salt
Prior art date
Application number
MA051521A
Other languages
English (en)
Inventor
Marco Cantarini
Marco Maria Gentile
Lucia Prota
Original Assignee
Dompe Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Farm Spa filed Critical Dompe Farm Spa
Publication of MA51521A publication Critical patent/MA51521A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
MA051521A 2018-01-05 2019-01-03 Compositions pharmaceutiques à libération immédiate contenant un sel de lysine de kétoprofène MA51521A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18150490.3A EP3508199A1 (fr) 2018-01-05 2018-01-05 Compositions pharmaceutiques à libération immédiate contenant un sel de lysine de kétoprofène

Publications (1)

Publication Number Publication Date
MA51521A true MA51521A (fr) 2021-04-14

Family

ID=60935752

Family Applications (1)

Application Number Title Priority Date Filing Date
MA051521A MA51521A (fr) 2018-01-05 2019-01-03 Compositions pharmaceutiques à libération immédiate contenant un sel de lysine de kétoprofène

Country Status (9)

Country Link
US (1) US20210077408A1 (fr)
EP (2) EP3508199A1 (fr)
CN (1) CN111587108B (fr)
BR (1) BR112020011573A2 (fr)
CA (1) CA3085658A1 (fr)
IL (1) IL275806A (fr)
MA (1) MA51521A (fr)
SG (1) SG11202005381PA (fr)
WO (1) WO2019134940A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116462202B (zh) * 2023-03-21 2024-06-14 东沃同泰(凤城)生物工程有限公司 一种羧酸修饰二氧化硅气凝胶及其制备方法和应用、药物递送体系

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
US6291527B1 (en) * 1998-04-11 2001-09-18 Errekappa Euroterapici S.P.A. Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
US20040013613A1 (en) * 2001-05-18 2004-01-22 Jain Rajeev A Rapidly disintegrating solid oral dosage form
US6316029B1 (en) * 2000-05-18 2001-11-13 Flak Pharma International, Ltd. Rapidly disintegrating solid oral dosage form
PT1312355E (pt) * 2001-11-20 2003-10-31 Applied Pharma Res Composicoes farmaceuticas nao-efervescentes soluveis em agua compreendendo drogas anti-inflamatorias nao-esteroides
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
US20140341988A1 (en) * 2013-05-15 2014-11-20 Apr Applied Pharma Research Sa Orally dispersible drug formulations
CN104987287B (zh) * 2015-06-10 2017-07-18 上海现代制药海门有限公司 一种球形酮基布洛芬赖氨酸盐的制备方法

Also Published As

Publication number Publication date
RU2020125247A3 (fr) 2022-02-07
CN111587108A (zh) 2020-08-25
EP3508199A1 (fr) 2019-07-10
RU2020125247A (ru) 2022-02-07
CN111587108B (zh) 2023-03-28
WO2019134940A1 (fr) 2019-07-11
EP3735227A1 (fr) 2020-11-11
IL275806A (en) 2020-08-31
BR112020011573A2 (pt) 2021-03-23
SG11202005381PA (en) 2020-07-29
CA3085658A1 (fr) 2019-07-11
US20210077408A1 (en) 2021-03-18

Similar Documents

Publication Publication Date Title
MA52421A (fr) Composés pharmaceutiques
EP3565550A4 (fr) Compositions pharmaceutiques contenant du méloxicam
EP3621621A4 (fr) Compositions pharmaceutiques contenant du méloxicam
FR26C1014I1 (fr) Compositions pharmaceutiques contenant de l'insuline
MA49947A (fr) Compositions pharmaceutiques contenant des anticorps anti-bêta-amyloïdes
EP3541385A4 (fr) Formulations pharmaceutiques
EP3573614C0 (fr) Compositions pharmaceutiques pour thérapie combinée
IL276569A (en) Hypertonic pharmaceutical preparations containing a chemical protective agent against platinum
MA55015A (fr) Formulations pharmaceutiques
EP4289478C0 (fr) Composition pharmaceutique d'edaravone
MA52756A (fr) Compositions pharmaceutiques stables pour inhalateurs doseurs sous pression
HUE059584T2 (hu) Gyógyszerészeti készítmény vérszegénység kezelésére
FR3022462B1 (fr) Composition orale d'anticorps anti-tnfalpha
EP3914234A4 (fr) Compositions pharmaceutiques
EP3526195A4 (fr) Sulfoxyalkyle organonitro, composés apparentés et compositions pharmaceutiques destinées à être utilisées en médecine
MA40781A (fr) Composition pharmaceutique d'isotrétinoïne à faible dosage destinée à la voie orale
PL3360547T3 (pl) Bakteriobójcza kompozycja farmaceutyczna zawierająca ibuprofen
MA49837A (fr) Compositions pharmaceutiques
EP3313380A4 (fr) Composition pour l'administration d'agents actifs à un animal
EP3582759A4 (fr) Composition pharmaceutique bioéquivalente de bromhydrate de vortioxétine
EP3302477A4 (fr) Formulations pharmaceutiques pour la libération prolongée d'ester de dinalbuphine de sébacoyle
PL3790554T3 (pl) Kompozycja farmaceutyczna do kontrolowanego uwalniania treprostynilu
EP3773613A4 (fr) Compositions pharmaceutiques contenant des polyrotaxanes
EP3244930A4 (fr) Compositions pharmaceutiques contenant des dérivés de poh
EP3375438A4 (fr) Comprimé oral triple à libération prolongée contenant de la prégabaline